Author

Reshma Shringarpure 1

1 Intercept Pharmaceuticals, Inc., San Diego, United States of America

Positive Results from REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for Nonalcoholic Steatohepatitis

Zobair Younossi, Vlad Ratziu, Rohit Loomba, Mary Rinella, Quentin Anstee, Zachary Goodman, Pierre Bedossa, Andreas Geier, Susanne Beckebaum, Philip Newsome, David Sheridan, James Trotter, Whitfield Knapple, Eric Lawitz, Kris V. Kowdley, Aldo Montano-Loza, Jérôme Boursier, Philippe Mathurin, Elisabetta Bugianesi, Giuseppe

REGENERATE: A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF OBETICHOLIC ACID THERAPY FOR NONALCOHOLIC STEATOHEPATITIS

Vlad Ratziu, Arun J Sanyal, Leigh MacConell, Reshma Shringarpure, Tonya Marmon, David Shapiro, Zobair Younossi

TREATMENT WITH OBETICHOLIC ACID IN PATIENTS WITH NASH DOES NOT SHOW INCREASED MARKERS OF LIVER TOXICITY BASED ON EVALUATION OF DRUG-INDUCED SERIOUS HEPATOTOXICITY (EDISH)

Arun J Sanyal, Paul Pockros, Amrik Shah, Reshma Shringarpure, David Shapiro, Aldo Trylesinski, Leigh MacConell

Item 1 - 3 / 3
1